Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769234 · ClinicalTrials.gov registry record
EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
A clinical trial, sponsored by Neuronetrix.
- Completed
- Registry status
- 75
- Enrollment target
NCT02769234: Completed study, sponsored by Neuronetrix.
NCT02769234 is a clinical trial that has completed, run by Neuronetrix. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769234 has completed, sponsored by Neuronetrix.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
In a previous study, NCT00582127, two age-matched cohorts, one clinically diagnosed with mild Alzheimer's disease and the other healthy controls, were tested with a hand-held EEG/ERP system to determine if the cohorts could be discriminated using the EEG/ERP measures. This study proposes to retest the AD cohort 18-60 months after their first test to characterize the change in EEG/ERP measures correlated with the longitudinal change in neuropsychological testing.
Interventions
- PROCEDURE ERP/EEG test
- PROCEDURE Psychometric testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02769234
The ClinicalTrials.gov registry entry for NCT02769234 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetrix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ERP/EEG test is the first listed.
NCT02769234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02769234 about?
NCT02769234 is a clinical study titled "EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)". In a previous study, NCT00582127, two age-matched cohorts, one clinically diagnosed with mild Alzheimer's disease and the other healthy controls, were tested with a hand-held EEG/ERP system to determine if the cohorts could be discriminated using the EEG/ERP measures. This study proposes to retest t...
What is the current status of trial NCT02769234?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02769234?
The interventions under investigation include: ERP/EEG test (PROCEDURE), Psychometric testing (PROCEDURE).
Who is sponsoring clinical trial NCT02769234?
This trial is sponsored by Neuronetrix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.